TrimGen Corp Cleared for Warfarin Genotyping Kit
TrimGen Corp, a molecular diagnostic company, announced that it has received FDA 510(k) clearance to market its eQ-PCR LC Warfarin Genotyping kit.
Read MoreMonth: February 2009
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
Agendia has announced that a study demonstrating the direct predictive ability of its breast cancer recurrence test, MammaPrint, has been published inBreast Cancer Research and Treatment.
Read MoreStudy on Diagnocure’s GCC Biomarker Published in JAMA
JAMA has published positive results from a major prospective 5-year multicenter study of over 400 enrolled patients demonstrating that guanylyl cyclase C (GCC) is the strongest independent predictor of colorectal cancer recurrence in patients considered low risk.
Read MoreExagen Diagnostics Names New VP and COO
Exagen Diagnostics Inc announces that John Alsobrook, PhD, has been named vice president and chief operating officer.
Read MoreObama Signs Massive Stimulus Package
President Barack Obama has signed a massive $787 billion package to revive the economy, saying the measure represented the “essential work of keeping the American dream alive in our time.”
Read More